lapatinib has been researched along with moclobemide in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (moclobemide) | Trials (moclobemide) | Recent Studies (post-2010) (moclobemide) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 788 | 240 | 113 |
| Protein | Taxonomy | lapatinib (IC50) | moclobemide (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 7.7 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 4.1522 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
1 other study(ies) available for lapatinib and moclobemide
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |